Section Arrow
Quote
BNR.NASDAQ
- Burning Rock Biotech Limited
Quotes are at least 15-min delayed:2026/03/30 06:06 EDT
Pre Market
Last
 16.35
-0.01 (-0.06%)
Bid
16.21
Ask
16.36
High 16.7 
Low 16.35 
Volume 530 
Regular Hours (Closed)
Last
 16.36
-2.14 (-11.57%)
Day High 
18.81 
Prev. Close
18.5 
1-M High
26.34 
Volume 
32.22K 
Bid
16.21
Ask
16.36
Day Low
16.16 
Open
18.81 
1-M Low
15.4 
Market Cap 
199.18M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 18.47 
20-SMA 20.95 
50-SMA 27.37 
52-W High 41.72 
52-W Low 2.18 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-11.60/--
Enterprise Value
226.94M
Balance Sheet
Book Value Per Share
7.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
515.82M
Operating Revenue Per Share
7.50
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
DHRDanaher Corp181.52-6.13-3.27%37.31PE
Pre Market 181.88 +0.36 +0.20%
OPKOPKO Health1.12-0.05-4.27%-- 
Pre Market 1.113 -0.007 -0.63%
PSNLPersonalis6.34-0.98-13.39%-- 
Pre Market 6.36 +0.02 +0.32%
BIAFbioAffinity Technologies Inc4-0.74-15.61%-- 
Pre Market 4.06 +0.06 +1.50%
SHCSotera Health Company13.13-0.41-3.03%50.15PE
Pre Market -- -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.